The Global Diabetes Compact aims to improve diagnosis, care, and access to life-saving medications for those with diabetes. Already, countries in high-burden regions have improved along these key metrics. But as the number of people living with diabetes is projected to increase nearly 50% globally by 2050, much more needs to be accomplished.  In a […] Continue reading ->
Three leading Geneva-based non-profit organisations involved in the research and development (R&D) of “effective, affordable, and life-saving medicines” are pooling resources to address the growing unmet needs of the world’s most vulnerable patients. The Drugs for Neglected Diseases initiative (DNDi), the Global Antibiotic Research and Development Partnership (GARDP), and Medicines for Malaria Venture (MMV) announced […] Continue reading ->
Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading ->
This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading ->
The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading ->
In an era of big global health budget cuts that often demand tough choices, identifying vaccine needs and priorities at national level is increasingly important. As we observe World Immunization Week, it’s time to recognize the pivotal role that National Immunization Technical Advisory Groups (NITAGs) can play in guiding effective, evidence-based decisions – alongside global […] Continue reading ->
US Health and Human Services Secretary Robert F Kennedy Jr offered contradictory responses that the country’s new leader of the Centers for Disease Control and Prevention (CDC) would be able to make decisions independent of political interference, especially around vaccines. The White House announced late last week its fourth pick in a year for CDC director, […] Continue reading ->
Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical  company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading ->